Original language | English |
---|---|
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 28 |
Publication status | Published - Sept-2017 |
Event | 42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8-Sept-2017 → 12-Sept-2017 |
Functional genomic mRNA (FGmRNA) profiling of > 18,000 tumor samples identifies potential new indications for antibody-drug conjugates (ADCs) in a broad range of tumor types
K. L. Moek, D. J. de Groot, E. G. E. de Vries, R. S. N. Fehrmann
Research output: Contribution to journal › Meeting Abstract › Academic